Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
(Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | (FY)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 41.24%744.35M | 28.98%570.51M | -4.50%1.95B | -5.29%446.26M | 534.19M | 527.01M | 442.34M | 0.62%2.04B | 471.17M | 9.12%2.03B |
Cost of revenue | 32.37%496.58M | 40.11%393.13M | 4.93%1.34B | 16.66%312.98M | 375.84M | 375.14M | 280.58M | -13.76%1.28B | 268.28M | 28.30%1.49B |
Gross profit | 63.14%247.76M | 9.66%177.38M | -20.39%605.25M | -34.31%133.28M | 158.35M | 151.87M | 161.76M | 39.94%760.31M | 202.89M | -22.56%543.3M |
Operating expense | 4.85%186.2M | 7.30%192.04M | 8.02%738.43M | 14.62%192.41M | 189.45M | 177.59M | 178.97M | 11.42%683.58M | 167.87M | 19.83%613.51M |
Operating profit | 339.33%61.56M | 14.81%-14.66M | -273.57%-133.18M | -268.88%-59.14M | -31.11M | -25.72M | -17.21M | 209.29%76.73M | 35.02M | -137.04%-70.21M |
Net non-operating interest income (expenses) | -750.00%-51K | -650.00%-45K | 86.71%-23K | 91.38%-5K | -6K | -6K | -6K | 81.20%-173K | -58K | 32.25%-920K |
Non-operating interest expense | 750.00%51K | 650.00%45K | -86.71%23K | -37.50%5K | --6K | --6K | --6K | -81.20%173K | --8K | -32.25%920K |
Net investment income | 0 | 2.9M | ||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 0 | 0 | -101.34%-167K | -87K | 2,791.38%12.49M | |||||
Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 101.34%167K | --87K | -1,952.82%-12.49M |
Other non-operating income (expenses) | 155.16%139K | 101.09%132K | -737.67%-10.68M | 7.39%1.66M | 47K | -252K | -12.13M | -29.00%1.68M | 1.54M | 1,056.37%2.36M |
Income before tax | 337.28%61.65M | 60.22%-11.68M | -284.31%-143.89M | -257.86%-57.49M | -31.07M | -25.98M | -29.35M | 238.71%78.07M | 36.42M | -129.94%-56.28M |
Income tax | -57.96%7.94M | 0 | -9.25%3.9M | -5,754.14%-7.52M | 0 | 18.89M | -7.47M | 173.78%4.3M | 133K | -116.14%-5.83M |
Net income | 219.69%53.71M | 46.65%-11.68M | -300.36%-147.79M | -237.71%-49.97M | -31.07M | -44.87M | -21.89M | 246.21%73.76M | 36.28M | -133.23%-50.45M |
Net income continuous operations | 219.69%53.71M | 46.65%-11.68M | -300.36%-147.79M | -237.72%-49.97M | ---31.07M | ---44.87M | ---21.89M | 246.21%73.76M | --36.28M | -133.23%-50.45M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 219.69%53.71M | 46.65%-11.68M | -300.36%-147.79M | -237.71%-49.97M | -31.07M | -44.87M | -21.89M | 246.21%73.76M | 36.28M | -133.23%-50.45M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 219.69%53.71M | 46.65%-11.68M | -300.36%-147.79M | -237.71%-49.97M | -31.07M | -44.87M | -21.89M | 246.21%73.76M | 36.28M | -133.23%-50.45M |
Gross dividend payment | ||||||||||
Basic earnings per share | 216.79%22.33 | 50.86%-4.85 | -286.58%-62.77 | -226.75%-20.91 | -12.87 | -19.12 | -9.87 | 244.38%33.6432 | 16.4976 | -136.25%-23.3021 |
Diluted earnings per share | 216.79%22.33 | 50.86%-4.85 | -286.58%-62.77 | -236.11%-20.91 | -12.9162 | -19.12 | -9.87 | 244.38%33.6432 | 15.3627 | -136.25%-23.3021 |
Dividend per share | ||||||||||
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |